1. Home
  2. DMRA vs WB Comparison

DMRA vs WB Comparison

Compare DMRA & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$20.40

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Weibo Corporation

WB

Weibo Corporation

N/A

Current Price

$6.37

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DMRA
WB
Founded
2011
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
DMRA
WB
Price
$20.40
$6.37
Analyst Decision
Strong Buy
Buy
Analyst Count
10
17
Target Price
★ $46.89
$8.24
AVG Volume (30 Days)
607.7K
★ 883.9K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
★ 9.44%
EPS Growth
★ 121.48
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$0.11
Revenue Next Year
N/A
$0.78
P/E Ratio
★ N/A
$5.66
Revenue Growth
N/A
N/A
52 Week Low
$16.50
$6.37
52 Week High
$34.89
$12.77

Technical Indicators

Market Signals
Indicator
DMRA
WB
Relative Strength Index (RSI) 31.99 32.11
Support Level $18.99 N/A
Resistance Level $26.76 $6.79
Average True Range (ATR) 1.59 0.10
MACD -0.18 0.02
Stochastic Oscillator 15.83 25.00

Price Performance

Historical Comparison
DMRA
WB

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About WB Weibo Corporation

Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.

Share on Social Networks: